Examination of nerve block effect on abdominal pain and low back pain in Parkinson's disease

Not Applicable

Recruiting

• Conditions: Parkinson' s disease

• Registration Number: JPRN-UMIN000047111
• Lead Sponsor: Osaka Toneyama Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-03-07
• Last Update Posted: 2 September 2024
• Study Completion: 2025-03-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with serious physical symptoms other than Parkinson's disease (cardiac / hepatic / renal dysfunction, hematopoietic disorders, etc.) 2) Viral hepatitis: HBsAg positive or HCV antibody positive 3) Women who are pregnant or may become pregnant 4) Patients with a history of hypersensitivity to the study drug 5) Patients with drug addiction / alcohol dependence 6) Patients with serious psychiatric symptoms (confusion, hallucinations, delusions, abnormal behavior, etc.) within 3 months before obtaining the consent form 7) Other patients who the doctor in charge deems inappropriate to participate in the study

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain Questionnaire including visual analogue scale (2 weeks, 4 weeks, 8 weeks, 12 weeks, 24 weeks after the block injection)

Secondary Outcome Measures

Name	Time	Method
nified Parkinson Disease Rating Scale, functional evaluation in rehabilitation, evaluation of waist bending angle (2 weeks, 4 weeks, 8 weeks, 12 weeks, 24 weeks after the block injection)